Search Within

Noushin Rahnamay Farnoud

Formats
  1. Journal Article (26)
  2. Meeting Abstract (22)
  3. Research Letter (3)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Department of Medicine (41)
  3. Hematologic Malignancies, Division of (39)
  4. Adult Leukemia (38)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (29)
  6. Executive Committee, Center for Hematologic Malignancies (29)

More Groups

People
  1. Raajit Rampal (24)
  2. Elli Papaemmanuil (21)
  3. Ross Levine (21)
  4. Erin McGovern (16)
  5. Juan Arango Ossa (16)
  6. Juan Medina (15)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Blood (24)
  2. Blood Advances (5)
  3. Clinical Cancer Research (3)
  4. Cancer Cell (2)
  5. Cancer Discovery (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (4)
  4. Cell Press (2)
  5. Amer Soc Clinical Investigation Inc (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A plug-and-play infrastructure for scalable bioinformatics operations
    Meeting Abstract

    Medina-Martinez, J. S.; Arango-Ossa, J. E.; Gundem, G.; Levine, M. F.; Patel, M.; Farnoud, N. R.; Yellapantula, V. D.; Teng, G.; McCarter, J. G.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial
    Journal Article

    Gangat, N.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Rademaker, A.; Fought, A. J.; Frankfurt, O.; Altman, J. K.; Wen, Q. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Oral idasanutlin in patients with polycythemia vera
    Journal Article

    Mascarenhas, J.; Lu, M.; Kosiorek, H.; Virtgaym, E.; Xia, L.; Sandy, L.; Mesa, R.; Petersen, B.; Farnoud, N.; Najfeld, V.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Ruxolitinib therapy followed by reduced-intensity conditioning for hematopoietic cell transplantation for myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study
    Journal Article

    Gupta, V.; Kosiorek, H. E.; Mead, A.; Klisovic, R. B.; Galvin, J. P.; Berenzon, D.; Yacoub, A.; Viswabandya, A.; Mesa, R. A.; Goldberg, J.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Tripodi, J.; Najfeld, V.; Petersen, B.; Rampal, R. K.; Farnoud, N.; Famulare, C.; Mascarenhas, J.; Hoffman, R.
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Talati, C.; Desai, P.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Sallman, D. A.; Lancet, J. E.; Roboz, G. J.; Sweet, K. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Alisertib (MLN8237), an oral selective inhibitor of aurora kinase A, has clinical activity and restores GATA1 expression in patients with myelofibrosis
    Meeting Abstract

    Gangat, N.; Stein, B. L.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Frankfurt, O.; Altman, J. K.; Wen, J. Q.; Farnoud, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
    Journal Article

    Xiao, W.; Bharadwaj, M.; Levine, M.; Farnhoud, N.; Pastore, F.; Getta, B. M.; Hultquist, A.; Famulare, C.; Medina, J. S.; Patel, M. A.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save